Abstract
Breast cancer and prostate cancer are the most common invasive types of cancers in women and men. Many of the recent advances in understanding the pathophysiology of breast and prostate cancers have paved the way for new treatment strategies. The alarming increase in the global cancer death toll has fueled the quest for new effective anti-tumor drugs through biological screening of both terrestrial and marine organisms. Recently, marine-derived natural bioactive products, isolated from aquatic fungi, cyanobacteria, sponges, algae, and tunicates, have been found to exhibit various anti-cancer activities including anti-angiogenic, anti-proliferative, inhibition of topoisomerase activities and induction of apoptosis. Thus, marine derived chemical derivatives such as alkaloids, macrolides, terpenes and other miscellaneous compounds possess anticancer properties. Hence, this review discusses the role of marine compounds on breast and prostate cancer.
Keywords: Alkaloids, breast, cancer, macrolides, prostate, spongistatin.
Current Bioactive Compounds
Title:Marine Derived Bioactive Compounds for Breast and Prostate Cancer Treatment: A Review
Volume: 10 Issue: 1
Author(s): Senthilkumar Kalimuthu, Jayachandran Venkatesan and Se-Kwon Kim
Affiliation:
Keywords: Alkaloids, breast, cancer, macrolides, prostate, spongistatin.
Abstract: Breast cancer and prostate cancer are the most common invasive types of cancers in women and men. Many of the recent advances in understanding the pathophysiology of breast and prostate cancers have paved the way for new treatment strategies. The alarming increase in the global cancer death toll has fueled the quest for new effective anti-tumor drugs through biological screening of both terrestrial and marine organisms. Recently, marine-derived natural bioactive products, isolated from aquatic fungi, cyanobacteria, sponges, algae, and tunicates, have been found to exhibit various anti-cancer activities including anti-angiogenic, anti-proliferative, inhibition of topoisomerase activities and induction of apoptosis. Thus, marine derived chemical derivatives such as alkaloids, macrolides, terpenes and other miscellaneous compounds possess anticancer properties. Hence, this review discusses the role of marine compounds on breast and prostate cancer.
Export Options
About this article
Cite this article as:
Kalimuthu Senthilkumar, Venkatesan Jayachandran and Kim Se-Kwon, Marine Derived Bioactive Compounds for Breast and Prostate Cancer Treatment: A Review, Current Bioactive Compounds 2014; 10 (1) . https://dx.doi.org/10.2174/1573407210666140327212945
DOI https://dx.doi.org/10.2174/1573407210666140327212945 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Exploring and Exploiting Biologically Relevant Chemical Space
Current Drug Targets Seeds of Peganum Harmala L. Chemical Analysis, Antimalarial and Antioxidant Activities, and Cytotoxicity Against Human Breast Cancer Cells
Medicinal Chemistry Anticarcinogenic Effects of Capsaicin-Loaded Nanoparticles on In vitro Hepatocellular Carcinoma
Current Chemical Biology Compounds From Celastraceae Targeting Cancer Pathways and Their Potential Application in Head and Neck Squamous Cell Carcinoma: A Review
Current Genomics Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems
Current Medicinal Chemistry Ischemic Colitis: Current Diagnosis and Treatment
Current Drug Targets High Order Texture-Based Analysis in Biomedical Images
Current Medical Imaging The Use of Metabolising Systems for In Vitro Testing of Endocrine Disruptors
Current Drug Metabolism HER-2 Signaling and Inhibition in Breast Cancer
Current Cancer Drug Targets Systemic and Biophase Bioavailability and Pharmacokinetics of Nanoparticulate Drug Delivery Systems
Current Drug Delivery Applications of Natural Polymeric Materials in Solid Oral Modified-Release Dosage Forms
Current Pharmaceutical Design Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery
Current Medicinal Chemistry Recent Advances in Validating MDM2 as a Cancer Target
Anti-Cancer Agents in Medicinal Chemistry Investigation of <i>ACE rs4646994, MTHFR rs1801133</i> and <i>VDR rs2228570</i> Genotypes in Jordanian Patients with Fibromyalgia Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets Does the MK2-dependent Production of TNFα Regulate mGluR-dependent Synaptic Plasticity?
Current Neuropharmacology Patent Selections
Recent Patents on Regenerative Medicine Rationale for an Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer
Recent Patents on Anti-Cancer Drug Discovery Impact of Drug Metabolism/Pharmacokinetics and their Relevance Upon Traditional Medicine-based Cardiovascular Drug Research
Current Drug Metabolism <i>Uncaria rhynchophylla</i> and its Major Constituents on Central Nervous System: A Review on Their Pharmacological Actions
Current Vascular Pharmacology Meet Our Editorial Board Member
Current Medicinal Chemistry